Low expression of DIRAS3 is associated with high malignancy of ovarian, breast, and prostatic cancers, while high expression predicts good prognosis of ovarian and pancreatic cancers (Dalai et al. 2007). The gene discussed is DIRAS3; the disease is familial pancreatic carcinoma.